A new trading day began on Monday, with Neumora Therapeutics Inc (NASDAQ: NMRA) stock price up 8.04% from the previous day of trading, before settling in for the closing price of $2.24. NMRA’s price has ranged from $0.61 to $11.57 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 6.66%. With a float of $54.47 million, this company’s outstanding shares have now reached $161.95 million.
Neumora Therapeutics Inc (NMRA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Neumora Therapeutics Inc is 67.40%, while institutional ownership is 19.04%. The most recent insider transaction that took place on Nov 11 ’25, was worth 307,026. In this transaction an insider of this company sold 114,703 shares at a rate of $2.68, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Director proposed sale 114,703 for $2.68, making the entire transaction worth $307,027.
Neumora Therapeutics Inc (NMRA) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.37 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.66% per share during the next fiscal year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Here are Neumora Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
Compared to the last year’s volume of 1.86 million, its volume of 1.35 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 31.63%.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 62.90%, which indicates a significant increase from 35.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.23, while its 200-day Moving Average is $1.46. Nevertheless, the first resistance level for the watch stands at $2.56 in the near term. At $2.69, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.80. If the price goes on to break the first support level at $2.32, it is likely to go to the next support level at $2.21. Should the price break the second support level, the third support level stands at $2.08.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
With a market capitalization of 404.36 million, the company has a total of 167,089K Shares Outstanding. Currently, annual sales are 0 K while annual income is -243,790 K. The company’s previous quarter sales were 0 K while its latest quarter income was -56,760 K.
